Has Casey Lowrey received payments from drug or device companies?

Yes. Drug and device makers reported $4,490 in general payments to Casey Lowrey across 261 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Casey Lowrey did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Casey Lowrey come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Casey Lowrey

Child & Adolescent Psychiatry · Birmingham, ALNPI 1831623891

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations.

$4,490in general payments, 2019–2025

Across 261 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$818
Axsome Therapeutics, Inc.$396
Corium, LLC$365
Vanda Pharmaceuticals Inc.$327
Teva Pharmaceuticals USA, Inc.$323
Supernus Pharmaceuticals, Inc.$270
plus $2K from 17 others

What the payments were for

Food & beverage$4,490100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	50	$818
Axsome Therapeutics, Inc.	20	$396
Corium, LLC	21	$365
Vanda Pharmaceuticals Inc.	17	$327
Teva Pharmaceuticals USA, Inc.	21	$323
Supernus Pharmaceuticals, Inc.	11	$270
Johnson & Johnson	13	$267
Alkermes, Inc.	13	$236
AbbVie	29	$226
Tris Pharma Inc	12	$215
Otsuka America Pharmaceutical, Inc.	10	$214
Lundbeck LLC	7	$136
Almatica Pharma LLC	6	$113
Bausch Health US, LLC	6	$103
Takeda Pharmaceuticals U.S.A., Inc.	5	$98
Ironshore Pharmaceuticals Inc.	5	$93
Collegium Pharmaceutical, Inc.	4	$72
Neurocrine Biosciences, Inc.	2	$67
Neos Therapeutics, LP	3	$47
E.r. Squibb & Sons, L.L.C.	2	$40
Vertical Pharmaceuticals, LLC	2	$34
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$15
Noven Therapeutics, LLC	1	$14

How this compares

$4,490 in reported general payments places this provider in the 85th percentile of 40 child & adolescent psychiatry providers in Alabama.

See all child & adolescent psychiatry providers in Alabama →

Other child & adolescent psychiatry in Birmingham

Artie NelsonBirmingham$32K
Karen CallahanBirmingham$5K
Elizabeth FergusonBirmingham$1K
Srilata AnneBirmingham$1K
Stewart WaddellBirmingham$1K
Abhishek WadhwaBirmingham$978
Francisca MgbodileBirmingham$582
James CullinanBirmingham$57
Tom VaughanBirmingham$49
Tolulope PetersBirmingham$35

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →